Clinical Trials
MabThera meets primary endpoint in PEMPHIX trial in pemphigus vulgaris
Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52.
The...
Clinical Trials
WellVia partners with Health Gorilla to power clinical record retrieval and lab ordering
Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced a partnership that enables new data exchange capabilities within the...
Clinical Trials
Replimune Provides Update on RP1 Clinical Development Program in Cutaneous Squamous Cell Carcinoma
Replimune Group Inc. , a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, announced that the first patient has been enrolled in...
Clinical Trials
Academic Medical Center System Infrastructure Trends and Related Challenges for Conducting Clinical Trials
Though academic medical centers (AMCs) may differ widely—public vs private, city vs rural, and system infrastructure and resource variations—they generally share the same tripartite mission:...
Clinical Trials
Parexel Expands Phase I Research Capabilities in Greater China region with New Early Phase Clinical Unit Alliances
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization,...
Clinical Trials
Sharp’s Netherlands Facility Approved for Clinical Operations
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational...
Clinical Trials
Catalent To Open New Clinical Supply Facility In San Diego
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced it is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.